Large language models are increasingly used to generate synthetic clinical notes and EHR-like datasets, lowering the barrier to entry for smaller healthcare teams. The practical constraint is no longer generation—it’s proving clinical fidelity and preventing leakage before these datasets touch high-stakes workflows.
LLMs accelerate synthetic clinical notes and EHR generation, but clinical validation lags
Recent research summarized by PubMed Central (Nov. 8, 2025) describes large language models (LLMs) as a viable alternative for generating synthetic clinical data, including clinical notes and electronic health records (EHRs). The coverage highlights frameworks such as MedSyn, which uses medical knowledge graphs to improve clinical realism while aiming to preserve patient privacy.
The core shift is operational: teams can prototype and iterate on synthetic datasets with less specialized domain expertise and without “massive” GPU infrastructure. That democratizes access for smaller healthcare organizations and startups—but it also raises the bar on validation, especially if synthetic records are used beyond early-stage model development.
- Cost and capability shift: If LLM-based generators reduce compute and expertise requirements, synthetic data becomes a realistic option for smaller orgs that previously couldn’t justify bespoke simulation pipelines.
- Validation becomes the gating function: The risk moves from “can we generate data?” to “can we demonstrate clinical accuracy and suitability for the intended use,” particularly for clinical trials, patient care, or other high-stakes settings.
- Privacy work doesn’t disappear: Privacy engineers still need rigorous leakage checks and governance controls, because “synthetic” is not automatically non-identifying in practice.